Last reviewed · How we verify

carbon-14-[14C]-ANG-3777

Angion Biomedica Corp · Phase 1 active Small molecule

carbon-14-[14C]-ANG-3777 is a Small molecule drug developed by Angion Biomedica Corp. It is currently in Phase 1 development. Also known as: Hepatocyte growth factor mimetic.

At a glance

Generic namecarbon-14-[14C]-ANG-3777
Also known asHepatocyte growth factor mimetic
SponsorAngion Biomedica Corp
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about carbon-14-[14C]-ANG-3777

What is carbon-14-[14C]-ANG-3777?

carbon-14-[14C]-ANG-3777 is a Small molecule drug developed by Angion Biomedica Corp.

Who makes carbon-14-[14C]-ANG-3777?

carbon-14-[14C]-ANG-3777 is developed by Angion Biomedica Corp (see full Angion Biomedica Corp pipeline at /company/angion-biomedica-corp).

Is carbon-14-[14C]-ANG-3777 also known as anything else?

carbon-14-[14C]-ANG-3777 is also known as Hepatocyte growth factor mimetic.

What development phase is carbon-14-[14C]-ANG-3777 in?

carbon-14-[14C]-ANG-3777 is in Phase 1.

Related